glp 1 drugs novo nordisk Ozempic's patent problem: how lost control of a blockbuster drug. π Demand for GLP-1 weight-loss has exploded, turning Ozempic into a $40bn+ revenue engine for Novo Nordisk. But, despite Ozempic is first GLP-1 drug
Pay in 4 interest-free payments of $7.34 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours Β· Estimated delivery Aug 10 - Aug 15



























